This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
M Delaney . The case for patient access to experimental therapies. Journal of Infectious Diseases 1989;159:416–9.
MA Fischl , DD Richman , MH Grieco , The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine 1987;317:185–91
MA Sande , CCJ Arpener , CG Obiss , Antiretroviral therapy for adult HIV-infected patients recommendations from a state-of-the-art conference. Journal of the American Medical Association 1993;270:2583–9.
The Lancet 1993;342:1311–2.
B Freedman . Equipoise and the ethics of clinical research. New England Journal of Medicine 1987;317:141–5.
KJ Rothman , KB Michels . The continuing unethical use of placebo controls. New England Journal of Medicine 1994;331:394–8.
S Hellman , DS Hellman . Of mice but not men: problems of the randomized clinical trial. New England Journal of Medicine 1991;324:1585–9.
RD Mohr . AIDS, gays and state coercion. Bioethics 1987;1:35–50.
AF Shorr . AIDS and the FDA: an ethical case for limiting patient access to new medical therapies. IRB: A Review of Human Subjects Research 1992; 14(4): 1–5.
P Singer . Practical Ethics. Cambridge, United Kingdom: Cambridge University Press, 1993.
B Minogue , G Palmer-Fernandez , L Udell , BN Waller . Individual autonomy and the double-blind controlled experiment. Journal of Medicine and Philosophy 1995;20:43–55.
TR Fleming . Surrogate markers in AIDS and cancer trials. Statistics in Medicine 1994;13:1423–35.
S Ellenberg . Discussion of “surrogate markers in AIDS and cancer trials.” Statistics in Medicine 1994;13:1437–40.
On stopping a trial before its time. Lancet 1993;342:1311.
SS Ellenberg , D Finkelstein , DA Schoenfeld . Statistical issues arising in AIDS clinical trials. Journal of the American Statistical Association 1992;87:573–6.
DP Byar , DA Choenfeld , SB Reen , Design considerations for AIDS trials. New England Journal of Medicine 1990;323:1343–8.
SB Green Issues in the design of drug trials for AIDS. Controlled Clinical Trials 1990;11:80–7.
D Schwarz , J Lellouch . Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Disease 1967;20:637–48.